Cognition Therapeutics Inc SEC filings CGTX

Cognition Therapeutics Inc has 303 filings in SEC EDGAR's recent list, going back to Jan 29, 2009. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, listing notice). The company's fiscal year ends on December 31.

Cognition Therapeutics Inc SEC filings
Form Description Filed Period
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction May 4, 2026 May 1, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Dec 22, 2025 Dec 18, 2025
4 Insider transaction Dec 22, 2025 Dec 18, 2025
4 Insider transaction Dec 22, 2025 Dec 18, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 23, 2025 —
4 Insider transaction Sep 23, 2025 Sep 19, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction May 2, 2025 May 1, 2025
4 Insider transaction Feb 18, 2025 Feb 15, 2025
4 Insider transaction Feb 18, 2025 Feb 15, 2025
4 Insider transaction Feb 18, 2025 Feb 15, 2025
4 Insider transaction Feb 4, 2025 Feb 3, 2025
4 Insider transaction Feb 4, 2025 Feb 4, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 4, 2025 —
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction May 3, 2024 May 1, 2024
4 Insider transaction Mar 14, 2024 Mar 14, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 9, 2024 Feb 3, 2024
4 Insider transaction Feb 9, 2024 Feb 3, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
SC 13G Ownership over 5% (passive) Jan 19, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 13, 2023 —
3 Initial insider ownership Nov 13, 2023 Nov 8, 2023
4 Insider transaction Nov 13, 2023 Nov 8, 2023
4 Insider transaction Nov 13, 2023 Nov 8, 2023
4 Insider transaction Jun 13, 2023 Jun 9, 2023
4 Insider transaction Jun 13, 2023 Jun 9, 2023
4 Insider transaction Jun 13, 2023 Jun 9, 2023
4 Insider transaction Jun 13, 2023 Jun 9, 2023
4 Insider transaction Jun 13, 2023 Jun 9, 2023
4 Insider transaction Jun 13, 2023 Jun 9, 2023
4 Insider transaction May 3, 2023 May 1, 2023
3 Initial insider ownership May 3, 2023 May 1, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 15, 2023 —
4 Insider transaction Feb 7, 2023 Feb 3, 2023
4 Insider transaction Feb 7, 2023 Feb 3, 2023
SC 13D/A Amended ownership over 5% (active) Dec 5, 2022 —
4 Insider transaction Nov 29, 2022 Nov 29, 2022
4 Insider transaction Nov 29, 2022 Nov 28, 2022
4 Insider transaction Nov 29, 2022 Nov 28, 2022
SC 13G Ownership over 5% (passive) Nov 18, 2022 —
4 Insider transaction Nov 17, 2022 Nov 16, 2022
4 Insider transaction Nov 17, 2022 Nov 16, 2022
4 Insider transaction Nov 16, 2022 Nov 15, 2022
4 Insider transaction Nov 16, 2022 Nov 15, 2022
4 Insider transaction Nov 16, 2022 Nov 15, 2022
4 Insider transaction Nov 16, 2022 Nov 15, 2022
4 Insider transaction Sep 29, 2022 Sep 27, 2022
4 Insider transaction Sep 29, 2022 Sep 27, 2022
3 Initial insider ownership Aug 15, 2022 Aug 12, 2022
4/A Ownership document Jun 30, 2022 Jun 10, 2022
4/A Amended statement of changes in beneficial ownership of securities Jun 23, 2022 Jun 10, 2022
4/A Amended statement of changes in beneficial ownership of securities Jun 23, 2022 Jun 10, 2022
4/A Amended statement of changes in beneficial ownership of securities Jun 23, 2022 Jun 10, 2022
4/A Amended statement of changes in beneficial ownership of securities Jun 23, 2022 Jun 10, 2022
4/A Amended statement of changes in beneficial ownership of securities Jun 23, 2022 Jun 10, 2022
4 Insider transaction Jun 14, 2022 Jun 10, 2022
4 Insider transaction Jun 13, 2022 Jun 10, 2022
4 Insider transaction Jun 13, 2022 Jun 10, 2022
4 Insider transaction Jun 13, 2022 Jun 10, 2022
4 Insider transaction Jun 13, 2022 Jun 10, 2022
4 Insider transaction Jun 13, 2022 Jun 10, 2022
4 Insider transaction Mar 25, 2022 Mar 23, 2022
4 Insider transaction Mar 25, 2022 Mar 23, 2022
4 Insider transaction Feb 1, 2022 Jan 31, 2022
3 Initial insider ownership Feb 1, 2022 Jan 31, 2022
4/A Primary document Feb 1, 2022 Oct 13, 2021
4/A Primary document Feb 1, 2022 Oct 13, 2021
3/A Primary document Feb 1, 2022 Oct 7, 2021
3/A Primary document Feb 1, 2022 Oct 7, 2021
SC 13D/A Amended ownership over 5% (active) Feb 1, 2022 —
4 Insider transaction Nov 10, 2021 Nov 1, 2021
3 Initial insider ownership Nov 10, 2021 Nov 1, 2021
4 Insider transaction Nov 3, 2021 Nov 1, 2021
3 Initial insider ownership Nov 3, 2021 Nov 1, 2021
4 Insider transaction Oct 25, 2021 Oct 13, 2021
SC 13D Ownership over 5% (active) Oct 25, 2021 —
4 Insider transaction Oct 15, 2021 Oct 13, 2021
4 Insider transaction Oct 15, 2021 Oct 13, 2021
4 Insider transaction Oct 15, 2021 Oct 13, 2021
4 Insider transaction Oct 15, 2021 Oct 13, 2021
4 Insider transaction Oct 15, 2021 Oct 13, 2021
4 Insider transaction Oct 14, 2021 Oct 13, 2021
4 Insider transaction Oct 14, 2021 Oct 13, 2021
4 Insider transaction Oct 12, 2021 Oct 7, 2021
4 Insider transaction Oct 12, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021
3 Initial insider ownership Oct 7, 2021 Oct 7, 2021

Showing 127 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CGTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Purchase, NY
SEC filer status
, Emerging growth company
SEC CIK
1455365
Former names
COGNITION THERAPUTICS INC (until Dec 28, 2010)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.